Table 2.
Comparative characteristics of clinical data in treatment group and control group.
| Parameter | Control (n = 27) | Obese (n = 17) | T2D (n = 22) | p-Value |
|---|---|---|---|---|
| Age [years] | 42 (36.0–48.5) | 40 (26–42) | 45.5 (37.0–55.25) | p = 0.179 |
| BMI [kg/m2] | 23.2 (22.9–23.7) | 45 (42.2–5.2) | 44 (40.1–47.1) | p < 0.001 |
| HbA1c [%] | 5.2 (5.1–5.3) | 5.3 (5.2–5.5) | 6.25 (6.1–6.5) | p < 0.001 |
| Total cholesterol [mmol/l] | 5.1 (4.9–5.2) | 4.5 (3.6–5.0) | 3.9 (3.4–5.4) | p = 0.003 |
| HDL [mmol/l] | 0.98 (0.91–3.0) | 1.14 (1.13–1.23) | 1 (0.7–1.18) | p = 0.040 |
| LDL [mmol/l] | 3.16 (0.88) | 2.75 (0.65) | 2.73 (0.98) | p = 0.160 |
| TGs [mmol/l] | 0.9 (0.9–1.2) | 1.26 (0.9–1.7) | 1.6 (1.5–1.9) | p = 0.005 |
| ALT [U/l] | 20 (18.0–25.6) | 44 (28–91) | 47 (22.0–178.5) | p < 0.001 |
Data are presented as median (interquartile range) except for concentration of LDL (average). A p value of less than 0.05 was considered significant. Abbreviations: T2D (type 2 diabetes), BMI (body mass index), HbA1c (glycated hemoglobin), HDL (high density lipoprotein), LDL (low-density lipoprotein), TGs (triglycerides), ALT (alanine aminotransferase).